The present study was carried out to study the effect of the aqueous extract of the stem bark of Ficus bengalensis (F. bengalensis) Linn on animal models of pain. The study consisted of five groups of Swiss albino mice with eight mice in each group. The first group served as the control group and received only normal saline. The second, third, and fourth groups received the aqueous extract of F. bengalensis per orally (p.o.) in doses of 100, 200, and 400 mg/kg respectively. The last group received morphine intraperitoneally. The antinociceptive effect was studied using the tail-flick and formalin-induced pain tests. In the tail-flick test, a significant increase in the time elapsed till the animal flicked its tail from the source of thermal stimuli was obtained with all three tested doses of F. bengalensis extract as compared to the control group. In the early phase of the formalin test (0-5 min), a significant decrease in the duration of licking response was observed with F. bengalensis (at doses of 200 and 400 mg/kg) and morphine-treated groups as compared to the control group. In the late phase (25-30 min) of the formalin test, the duration was significantly reduced with all three treated doses of F. bengalensis when compared with the control group. A similar result was obtained with the morphine-treated group. The results indicate that F. bengalensis extract possesses significant antinociceptive activity in the mice.
Plants, as illustrated throughout the history of civilization, have served as a major source of medication for the treatment of human ailments. Medicinal plants are being increasingly used in both developing and developed countries not only as herbal medicines but also as dietary supplements. They contain many active constituents that are effective in the treatment of many human diseases. A large number of populations rely on herbal medicines because of their ethnic acceptability and compatibility, fewer side effects, and relatively low cost [1-2]. Although herbal medicines have existed since time immemorial, our knowledge of how plants actually affect human physiology remains largely unsettled. Medicinal plants have provided the basis for the discovery of many bioactive compounds that served and continue to serve as the lead molecule for the development of new drugs. F. bengalensis is one such medicinal plant. Ficus Linn (Family: Moraceae), with about 800 species of free-standing trees, hemiepiphytes, and shrubs, constitutes one of the largest genera of flowering plants primarily occurring in subtropical and tropical regions worldwide.
F. bengalensis Linn, commonly known as the Banyan tree or Vata or Vada, has a prominent place in Hindu religions and Ayurvedic medical literature. It is considered sacred in many places in India. F. bengalensis is reported to have several therapeutic uses in folk medicine . Its bark has been used for the treatment of diarrhea and dysentery, and its latex has been used for the treatment of hemorrhagic diarrhea, dysentery, and inflammation [4-5]. All parts of the plant have been used in both the Unani and Ayurveda systems of medicine as astringent, anodynia, anti-inflammatory, anti-arthritic, diaphoretic, antidiarrhoeal, and antiemetic [6-9]. The plant has also been known to possess antimicrobial and immunomodulatory properties [10-11]. The milky juice obtained from the stem, seed, or fruit of the banyan tree is used for the treatment of rheumatism and other inflammatory diseases in Ayurveda in India [9,12]. In experimental studies, the extract of F. bengalensis is also reported to possess antidiabetic, immunomodulatory, hypolipidemic, antioxidant, and antiasthmatic activity [9,13-15]. Throughout history, several forms of therapies have been used for the relief of pain; among them, the use of medicinally active plants has increased in developed and developing countries to promote healing and alleviate pain. As most of the analgesic drugs being used today exert a wide range of side effects, a study on plant species that are traditionally used as painkillers should still be seen as a logical and fruitful research strategy, in search of analgesic drugs. Although many properties of F. bengalensis have been reported in the past, the literature shows lacunae in the study of its analgesic effects, particularly in the background of nociceptive behavior. Nociception or pain is an unpleasant sensation localized to a part of the body. It is often penetrating in nature, or has tissue destructive processes (stabbing, burning, twisting, and squeezing), and having an emotional reaction. The present study was carried out to evaluate the antinociceptive activity of the aqueous bark extract of F. bengalensis in mice by using two methods, the tail-flick test and the formalin test.
Materials & Methods
This study was conducted in the department of pharmacology at University College of Medical Sciences, New Delhi, India. This is an experimental study done on animal models of pain. Two variables have been measured in the study, tail-flick latency and the formalin test.
Drugs and chemicals used in the study
Normal saline; commercially available bark extract of F. bengalensis; and morphine
Swiss albino mice of either sex, weighing between 25 and 30 grams were taken for the study. Animals were procured from the Central Animal House, University College of Medical Sciences, Delhi. Animals were housed in groups of eight mice per cage with a natural light/dark cycle and provided with free access to pellet diet and water. The study was approved by the Institutional Animal Ethics Committee (IAEC), University College of Medical Sciences, Delhi. Care of animals was taken as per the guidelines of Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).
The standardized aqueous bark extract of F. bengalensis was purchased from Tapovan Ayurved Sadan, Najafgarh, New Delhi, India (Member: Central Institute of Medicinal and Aromatic Plants, Lucknow, India). As per the literature provided by the manufacturer, the extract was found to contain flavonoids, terpenoids, tannins, saponins, sugars, glycosides, and phenolic compounds. For the purpose of this study, the F. bengalensis extract was dissolved in double distilled water to prepare suspensions of the required doses of 100, 200, and 400 mg/kg.
The extract was administered once in doses of 100, 200, and 400 mg/kg per orally (p.o.) one hour prior to the experiment, and morphine was administered in a dose of five mg/kg intraperitoneally, 30 minutes (min) prior to the experiment. Normal saline was administered to the control group. All drugs were administered in a volume of 10 ml/kg/dose. The animals were divided into five groups with eight mice in each group. The first group received only normal saline and served as the control group. The second, third, and fourth groups were administered the aqueous extract of F. bengalensis in doses of 100, 200, and 400 mg /kg p.o., respectively 60 min. prior to the experiment while the fifth group was injected with morphine in the dose of five mg/kg, 30 min prior to the experiment.
The tail-flick test was used in mice to elicit a spinal tail-flick response to noxious thermal stimuli. This test was used to measure the latency of the response as described by D’amour and Smith with modifications . The test was performed with the tail-flick analgesia meter (Ugo Basile, Italy), consisting of an infrared radiant light source. Each mouse was gently held with one hand and its tail was positioned on the source of radiant heat. When the animal flicked its tail from the point source in response to thermal noxious stimuli, both the heat source and the timer were automatically stopped. The time elapsed (in seconds) till the animal flicked its tail was determined. The test was done at 60 min. after the administration of F. bengalensis extract and 30 min. after morphine administration. A cut-off time of 10 seconds was used to prevent tissue damage.
The formalin test was done as described by Abbott et al. . Mice were injected with 0.05 ml of one percent formalin into the subplantar surface of the right hind paw. The left hind paw was injected normal saline and was considered the control. Animals were immediately returned individually into the testing chamber. The nociceptive response was quantified as the duration (in seconds) of licks and bites of the injected paw during the early phase (0-5 min) and late phase (25-30 min). Antinociceptive activity of F. bengalensis was assessed using single dose administration. Morphine was given intraperitoneally 30 min. prior and F. bengalensis extract was administered p.o. 60 min. prior to the induction of nociceptive behaviors in the animals.
The results were expressed as mean ± SEM. The data were analyzed statistically using one-way analysis of variance (ANOVA) followed by post hoc Tukey's test. P values less than 0.05 were considered significant. Statistical analysis of data was done using GraphPad Prism (GraphPad Software Inc., California, US) software.
Effects of F. bengalensis extract on the tail-flick latency test
The effect of the stem bark powder was evaluated in three doses in the tail-flick model of pain in mice. The pretreatment of mice with doses 100 mg/kg (p<0.05), 200 mg/kg (p<0.001), and 400 mg/kg (p<0.001) increased the mean tail-flick latency compared to the control group. Mice treated with morphine (five mg/kg) also showed an increase in tail-flick latency as compared to the control group (p<0.001) (Figure 1).
Effects of F. bengalensis extract on formalin-induced pain response
Injection of 0.05 ml of one percent formalin into the subplantar surface of the right hind paw induced a pain response that was quantified as the duration of licks and bites. The duration of pain response in the early phase (0-5 min) was significantly reduced in F. bengalensis (200 and 400 mg/kg) and morphine-treated groups as compared to the control group. In the late phase (25-30 min), the duration was significantly reduced with all three treated doses of F. bengalensis when compared with the control group. A similar result was obtained with the morphine-treated group as compared to the control group (Figure 2).
The present study was carried out to investigate the antinociceptive activity of the extract of F. bengalensis using two experimental models of pain, i.e. the tail-flick and formalin-induced pain response tests that employ thermal and chemical-induced nociception stimuli, respectively. These models are commonly used to evaluate central and peripheral analgesic activity of a compound. The tail-flick test, a well-known experimental model of pain, is used to assess the effectiveness of centrally acting analgesics. The analgesic action in tail-flick involves a spinal component and mediates the spinal reflex to painful stimuli [18-19]. In the present study, the oral administration of an aqueous extract of F. bengalensis in doses of 100, 200, and 400 mg/kg significantly prolonged the latency of nociceptive response in the tail-flick test in mice as compared to treatment with normal saline in the control group, suggesting a central analgesic effect of the extract. We can postulate that F. bengalensis exerted its analgesic effect by increasing the animal’s capacity to tolerate pain, which is an unpleasant sensation to part of its body.
The formalin-induced pain response model is used to measure both antinociceptive and anti-inflammatory responses and is more appropriate to measure the response to a long-lasting nociceptive stimulus in contrast to the tail-flick test . The nociceptive behavior in the formalin test is observed in two distinct phases-early and late phases-that indicate different types of pain . The early phase, named noninflammatory pain, corresponds to acute neurogenic pain and occurs as a result of the direct activation of nociceptors, thus reflecting centrally mediated pain. This phase is inhibited by opioid analgesics . The late phase, named inflammatory pain, occurs through the activation of ventral horn neurons at the spinal cord levels. This phase is attributed to the release of various inflammatory and hyperalgesic mediators, such as histamine, serotonin, bradykinins, and prostaglandins. This phase is inhibited by both centrally acting drugs, such as opioids, and peripherally acting drugs, such as cyclooxygenase inhibitors, and has been used to evaluate the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) which primarily inhibit the cyclooxygenase involved in prostaglandin synthesis . In the formalin-induced pain response test, the administration of F. bengalensis extract significantly prolonged the duration of pain response in both the early and late phases of the test. The antinociceptive effect observed in both pain models with F. bengalensis indicates the role of F. bengalensis in peripheral as well as central pain mechanisms. Based on this, it can be inferred that the peripheral analgesic effect observed with the F. bengalensis extract could be due to the inhibition of enzyme COX or any other inflammatory mediators, leading to the inhibition of prostaglandins synthesis.
A few studies on F. bengalensis have demonstrated its role in the hot plate and acetic acid-induced writhing models of pain sensitivity. This study is the first to demonstrate the effect of the aqueous extract of F. bengalensis in the formalin and tail-flick models in mice. Thakre et al. have reported that the administration of a methanol extract of F. bengalensis at doses of 200 mg and 400 mg/kg, p.o. caused a significant reduction in the frequency and time duration of writhing movements in the acetic acid-induced writhing test in mice . Similarly, Patil et al. revealed the analgesic and antipyretic properties of the various extracts from the bark of F. bengalensis using the hot-plate method and the tail-immersion method in rats . The anti-inflammatory effect of F. bengalensis has also been demonstrated in carrageenan-induced paw edema and cotton pellet- induced granuloma models in rats .
The extract of F. bengalensis contains various active principles, such as flavonoids, tannins, terpenoids, glycosides, carbohydrates, amino acid, and phenolic compounds. The tannins, terpenoids, and flavonoids isolated from various plant extracts have demonstrated anti-inflammatory and analgesic activity in various studies [25-26]. Different flavonoids molecules have been reported to have an inhibitory effect on various enzymes like phospholipase A2, cyclooxygenase, and lipoxygenase, thus reducing the production of the arachidonic acid, prostaglandins, and leukotrienes that are involved in the late phase of pain perception. They also inhibit other enzymes, such as protein kinase C, protein tyrosine kinases, phosphodiesterases, etc [27-28]. Terpenoids also exert significant analgesic and anti-inflammatory effect by inhibiting phospholipase A2, thereby preventing the synthesis of prostaglandins [29-30]. It is likely that the central and peripheral analgesic effect observed following the administration of F. bengalensis extract may be due to the presence of various phytochemicals, especially flavonoids, tannins, or terpenoids. Our study was aimed at evaluating the analgesic activity of aqueous bark extract of F. bengalensis. However, detailed studies are warranted in this direction to decode the exact nature of the phytochemical compounds responsible for the analgesic effects that could help in developing a drug that is effective and safer than the other analgesics used.
The findings of our study revealed the antinociceptive effect of F. bengalensis extract in the pain model of the tail-flick and formalin-induced response tests. In conclusion of our findings, we suggest that the aqueous extract of F. bengalensis is a promising analgesic agent and may be useful in the treatment of painful conditions and diseases. However, studies are required on human subjects to prove its clinical efficacy as an analgesic agent.
- Pal SK, Shukla Y: Herbal medicine: current status and the future. Asian Pac J Cancer Prev. 2003, 4:281-288.
- Singh P, Yadav RJ, Pandey A: Utilization of indigenous systems of medicine & homoeopathy in India. Indian J Med Res. 2005, 122:137-142.
- Mahajan MS, Gulecha VS, Khandare RA, Upaganlawar AB, Gangurde HH, Upasani CD: Anti-edematogenic and analgesic activities of Ficus benghalensis. Int J Nutr Pharmacol Neurol Dis. 2012, 2:100-104. 10.4103/2231-0738.95936
- Mukherjee PK, Saha K, Murugesan T, Mandal SC, Pal M, Saha BP: Screening of anti-diarrhoeal profile of some plant extracts of a specific region of West Bengal, India. J Ethnopharmacol. 1998, 60:85-89. 10.1016/S0378-8741(97)00130-X
- Patel MA, Patel PK, Patel MB: Aqueous extract of Ficus benghalensis Linn. Bark for inflammatory bowel disease. J Young Pharm. 2010, 2:130–136. 10.4103/0975-1483.63149
- Majumder P, Paridhavi M: An ethno-phytochemical and pharmacological review on novel Indian medicinal plants used in herbal formulations. Int J Pharm Pharm Sci. 2013, 5:74-83.
- Patil VV, Patil VR: Ficus Bengalensis Linn. An overview. Int J Pharma Bio Sci. 2010, 1:1-11.
- Patil VV, Pimprikar RB, Patil VR: Pharmacognostical studies and evaluation of anti-inflammatory activity of Ficus bengalensis Linn. J Young Pharm. 2009, 1:49-53.
- Thakare VN, Suralkar AA, Deshpande AD, Naik SR: Stem bark extraction of Ficus bengalensis Linn for anti-inflammatory and analgesic activity in animal models. Indian J Exp Biol. 2010, 48:39-45.
- Gaherwal S: Anti-bacterial activity of Ficus benghalensis (banyan) fruit extract against different bacteria. Int J Microbiol Res. 2013, 4:177-179.
- Gabhe SY, Tatke PA, Khan TA: Evaluation of the immunomodulatory activity of the methanol extract of Ficus benghalensis roots in rats. Indian J Pharmacol. 2006, 38:271-275. 10.4103/0253-7613.27024
- Manocha N, Chandra SK, Sharma V, Sangameswaran B, Saluja M: Anti-rheumatic and antioxidant activity of extract of stem bark of Ficus bengalensis. Res J Chem Sci. 2011, 1:2-8.
- Mahalingam G, Kannabiran K: Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozocin induced diabetic rats. Indian J Clin Biochem. 2008, 23:394-400.
- Shukla R, Gupta S, Gambhir JK, Prabhu KM, Murthy PS: Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits. J Ethnopharmacol. 2004, 92:47-51. 10.1016/j.jep.2004.01.020
- Daniel RS, Mathew BC, Devi KS, Augusti KT: Antioxidant effect of two flavonoids from the bark of Ficus bengalensis Linn in hyperlipidemic rats. Indian J Exp Biol. 1998, 36:902-906.
- D'Armour FE, Smith DL: A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941, 72:74-79.
- Abbott FV, Franklin KB, Westbrook RF: The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain. 1995, 60:91-102. 10.1016/0304-3959(94)00095-V
- Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev. 2001, 53:597-652.
- Wani TA, Kumar D, Prasad R, Verma PK, Sardar KK, Tandan SK, Kumar D: Analgesic activity of the ethanolic extract of Shorea robusta resin in experimental animals. Indian J Pharmacol. 2012, 44:493-499. 10.4103/0253-7613.99322
- Dubuisson D, Dennis SG: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977, 4:161-174. 10.1016/0304-3959(77)90130-0
- Leal LK, Ferreira AA, Bezerra GA, Matos FJ, Viana GS: Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study. J Ethnopharmacol. 2000, 70:151-159. 10.1016/S0378-8741(99)00165-8
- Shibata M, Ohkubo T, Takahashi H, Inoki R: Modified formalin test: characteristic biphasic pain response. Pain. 1989, 38:347-352. 10.1016/0304-3959(89)90222-4
- Damas J, Liégeois JF: The inflammatory reaction induced by formalin in the rat paw. Naunyn Schmiedebergs Arch Pharmacol. 1999, 359:220-227. 10.1007/PL00005345
- Patil VV, Bhangale SC, Narkhede SB, Jawle NM, Patil VR: Analgesic and antipyretic activities of Ficus bengalensis bark. Int J Pharm Res. 2010, 2:16-21.
- Fawole OA, Amoo SO, Ndhlala AR, Light ME, Finnie JF, Van Staden J: Anti-inflammatory, anticholinesterase, antioxidant and phytochemical properties of medicinal plants used for pain-related ailments in South Africa. J Ethnopharmacol. 2010, 127:235-241. 10.1016/j.jep.2009.11.015
- Kim HP, Son KH, Chang HW, Kang SS: Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004, 96:229-245. 10.1254/jphs.CRJ04003X
- Middleton E Jr: Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998, 439:175-182. 10.1007/978-1-4615-5335-9_13
- Chi YS, Jong HG, Son KH, Chang HW, Kang SS, Kim HP: Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem Pharmacol. 2001, 62:1185-1191. 10.1016/S0006-2952(01)00773-0
- Moody JO, Robert VA, Connolly JD, Houghton PJ: Anti-inflammatory activities of the methanol extracts and an isolated furanoditerpene constituent of Sphenocentrum jollyanum Pierre (Menispermaceae). J Ethnopharmacol. 2006, 104:87-91. 10.1016/j.jep.2005.08.051
- Neukirch H, D'Ambrosio M, Sosa S, Altinier G, Della Loggia R, Guerriero A: Improved anti-inflammatory activity of three new terpenoids derived, by systematic chemical modifications, from the abundant triterpenes of the flowery plant Calendula officinalis. Chem Biodivers. 2005, 2:657-671. 10.1002/cbdv.200590042
Antinociceptive Effect of Ficus bengalensis Bark Extract in Experimental Models of Pain
Ethics Statement and Conflict of Interest Disclosures
Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: The study was approved by the Institutional Animal Ethics Committee (IAEC), University College of Medical Sciences and Guru Teg Bahadur Hospital (UCMS & GTBH), Dilshad Garden, Delhi, India 110095. Regd. No.- 508/01/a/CPCSEA.
Care of animals was taken as per the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). Issued protocol number UCMS/IAEC/13. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Rajdev K, Jain S, C.h M, et al. (March 02, 2018) Antinociceptive Effect of Ficus bengalensis Bark Extract in Experimental Models of Pain. Cureus 10(3): e2259. doi:10.7759/cureus.2259
Received by Cureus: February 20, 2018
Peer review began: February 26, 2018
Peer review concluded: February 27, 2018
Published: March 02, 2018
© Copyright 2018
Rajdev et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.